These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26223682)

  • 1. Stratifin accelerates progression of lung adenocarcinoma at an early stage.
    Shiba-Ishii A; Kim Y; Shiozawa T; Iyama S; Satomi K; Kano J; Sakashita S; Morishita Y; Noguchi M
    Mol Cancer; 2015 Jul; 14():142. PubMed ID: 26223682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogen-induced tumors in SFN-transgenic mice harbor a characteristic mutation spectrum of human lung adenocarcinoma.
    Kim Y; Shiba-Ishii A; Ramirez K; Muratani M; Sakamoto N; Iijima T; Noguchi M
    Cancer Sci; 2019 Aug; 110(8):2431-2441. PubMed ID: 31144406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of stratifin in early progression of lung adenocarcinoma and its potential therapeutic relevance.
    Shiba-Ishii A
    Pathol Int; 2021 Oct; 71(10):655-665. PubMed ID: 34324245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma.
    Shiba-Ishii A; Kano J; Morishita Y; Sato Y; Minami Y; Noguchi M
    Int J Cancer; 2011 Nov; 129(10):2445-53. PubMed ID: 21207417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratifin Inhibits SCF
    Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
    Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
    Shiba-Ishii A; Noguchi M
    Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma.
    Kim Y; Shiba-Ishii A; Nakagawa T; Iemura SI; Natsume T; Nakano N; Matsuoka R; Sakashita S; Lee S; Kawaguchi A; Sato Y; Noguchi M
    Oncogene; 2018 Oct; 37(40):5387-5402. PubMed ID: 29880877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of stratifin (14-3-3 sigma) in adenocarcinoma of gallbladder: A novel prognostic biomarker.
    Sirivatanauksorn V; Dumronggittigule W; Dulnee B; Srisawat C; Sirivatanauksorn Y; Pongpaibul A; Masaratana P; Somboonyosdech C; Sripinitchai S; Kositamongkol P; Mahawithitwong P; Tovikkai C; Sangserestid P; Limsrichamrern S
    Surg Oncol; 2020 Mar; 32():57-62. PubMed ID: 31751820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
    Zhou LN; Li SC; Li XY; Ge H; Li HM
    Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression.
    Li Y; Miao L; Yu M; Shi M; Wang Y; Yang J; Xiao Y; Cai H
    Int J Oncol; 2017 Jun; 50(6):1955-1964. PubMed ID: 28440399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
    Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC
    Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low BIK outside-inside-out interactive inflammation immune-induced transcription-dependent apoptosis through FUT3-PMM2-SQSTM1-SFN-ZNF384.
    Huang J; Wang L; Jiang M; Chen Q; Zhang X; Wang Y; Jiang Z; Zhang Z
    Immunol Res; 2016 Apr; 64(2):461-9. PubMed ID: 26423071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.
    Patlolla JM; Kopelovich L; Qian L; Zhang Y; Kumar G; Madka V; Mohammed A; Biddick L; Sadeghi M; Lightfoot S; Rao CV
    Oncol Rep; 2015 Dec; 34(6):2925-34. PubMed ID: 26397133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM9 expression promotes an aggressive lung adenocarcinoma phenotype.
    Kossmann CM; Annereau M; Thomas-Schoemann A; Nicco-Overney C; Chéreau C; Batteux F; Alexandre J; Lemare F
    Tumour Biol; 2017 Jul; 39(7):1010428317716077. PubMed ID: 28675123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased susceptibility to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in transgenic mice overexpressing c-myc and epidermal growth factor in alveolar type II cells.
    Ehrhardt A; Bartels T; Klocke R; Paul D; Halter R
    J Cancer Res Clin Oncol; 2003 Feb; 129(2):71-5. PubMed ID: 12669230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma.
    Robin F; Angenard G; Cano L; Courtin-Tanguy L; Gaignard E; Khene ZE; Bergeat D; Clément B; Boudjema K; Coulouarn C; Sulpice L
    Br J Cancer; 2020 Jul; 123(1):72-80. PubMed ID: 32376891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
    Zhang L; Zhou XF; Pan GF; Zhao JP
    Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
    Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
    Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway.
    Yang ZT; Li Z; Wang XG; Tan T; Yi F; Zhu H; Zhao JP; Zhou XF
    Cell Physiol Biochem; 2015; 35(6):2360-70. PubMed ID: 25896422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.